Cellular immune response of ducks to duck hepatitis B virus infection

Journal of Medical Virology

Volumn 58, Issue 1, 1999, Pages 19-25

  Vickery, Karen ^a   Cossart, Yvonne ^a   Dixon, Robert ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antigen specific blastogenesis; Cell mediated immunity; Hepadnavirus

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CONTROLLED STUDY; DUCK; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; LYMPHOCYTE TRANSFORMATION; MALE; MONONUCLEAR CELL; NONHUMAN;

ACUTE DISEASE; ANIMALS; CHRONIC DISEASE; DUCKS; FEMALE; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B ANTIBODIES; HEPATITIS B VIRUS, DUCK; IMMUNITY, CELLULAR; LEUKOCYTES, MONONUCLEAR; LIVER; LYMPHOCYTE ACTIVATION; MALE; SPLEEN;

ANAS; ANAS SP.; ANIMALIA; DNA VIRUSES; DUCK HEPATITIS B VIRUS; HEPADNAVIRIDAE; HEPATITIS B VIRUS;

EID: 0032932146     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199905)58:1<19::AID-JMV3>3.0.CO;2-R     Document Type: Article

References (32)

1. Barnaba V, Franco A, Alberti A, Balsano C, Benvenuto R, Balsano F. 1989. Recognition of hepatitis B virus envelope proteins by liver-infiltrating T lymphocytes in chronic HBV infection. J Immunol 143:2650-2655.
2. Beasley RP, Hwang LY, Stevens CE, Lin CC, Hiseh FJ, Wang KY, Sun TS, Szmuness W. 1983. Efficacy of hepatitis B immune globulin (HBIg) for prevention of perinatal transmission of the HBV carrier state: final report of a randomized and double-blind placebo-controlled trial. Hepatology 3:135-141.
3. Bertram EM, Wilkinson RG, Lee BA, Jilbert AR, Kotlarski I. 1996. Identification of duck T lymphocytes using an anti-human T cell (CD3) antiserum. Vet Immunol Immunopathol 51:353-363.
4. Beutner KR, Tiku ML, Ogra PL. 1978. Hepatitis B surface antigen-specific cell-mediated immune responses in human chronic hepatitis B surface antigen carriers. Inf Immun 21:480-488.
5. Chisari FV. 1995. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 13:29-60.
6. Ferrari C, Penna A, Sansoni P, Giuberti T, Neri TM, Chisari FV, Fiaccadori F. 1986. Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin Exp Immunol 66:497-506.
7. Ferrari C, Penna A, Giuberti T, Tong MJ, Ribera E, Fiaccadori F, Chisari FV. 1987. Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol 139:2050-2058.
8. Ferrari C, Penna A, Bertoletti A, Cavalli A, Valli A, Schianchi C, Fiaccadori F. 1989. The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J Clin Invest 84: 1314-1319.
9. Ferrari C, Penna A, Bertoletti A, Valli A, Antoni AD, Giuberti T, Cavalli A, Petit MA, Fiaccadori F. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 145:3442-3449.
10. Freiman JS, Jilbert AR, Dixon RJ, Holmes M, Gowans EJ, Burrell CJ, Wills EJ, Cossart YE. 1988. Experimental duck hepatitis B virus infection: pathology and evolution of hepatic and extrahepatic infection. Hepatology 8:507-513.
11. Fukuda R, Fukumoto S, Shimada Y. 1987. A sequential study of viral DNA in serum in experimental transmission of duck hepatitis B virus. J Med Virol 21:311-320.
12. Hanson RG, Hoofnagle JH, Minuk GY, Purcell RH, Gerin JL. 1984. Cell-mediated immunity to hepatitis B surface antigen in man. Clin Exp Immunol 57:257-264.
13. Jilbert AR, Wu T-T, Englan JM, de la Hall P, Carp NZ, O'Connell AP, Mason WS. 1992. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 66: 1377-1388.
14. Jilbert AR, Botten JA, Miller DS, Bertram EM, Hall PM, Kotlarski J, Burrell CJ. 1998. Characterization of age-and dose-related outcomes of duck hepatitis B virus infection. Virology 244:273-282.
15. Jung MC, Spengler U, Schraut W, Hoffmann R, Zachoval R, Eisenburg J, Eichenlaub D, Riethmuller G, Paumgartner G, Ziegler-Heitbrock HWL, Will H, Pape GR. 1991. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol 13:310-317.
16. Kotwal GJ. 1997. Microorganisms and their interaction with the immune system. J Leukocyte Biol 62:415-429.
17. Marion PL, Knight SS, Feitelson MA, Oshiro LS, Robinson WS. 1983. Major polypeptide of duck hepatitis B surface antigen particles. J Virol 48:534-541.
18. McFadden G, Kane K. 1994. How DNA viruses perturb functional MHC expression to alter immune recognition. Adv Cancer Res 63:117-209.
19. Mondelli M, Vergani GM, Alberti A, Vergani D, Portmann B, Eddleston AL, Williams R. 1982. Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. J Immunol 129:2773-2778.
20. Nagafuchi S, Kashiwagi S, Tsuji Y, Miyata Y, Iwakiri R, Takeshita M, Niho Y, Kikuchi M. 1989. Delayed-type hypersensitivity skin reaction to HBsAg and immunohistopathologic study of liver in patients with acute type B viral hepatitis. Microbiol Immunol 33: 539-548.
21. Omata M, Yodosuka O, Imazeki F, Matsuyama Y, Uchiumi K, Ito Y, Mori J, Okuda K. 1984. Transmission of duck hepatitis B virus from Chinese carrier ducks to Japanese ducklings: a study of viral DNA in serum and tissue. Hepatology 4:603-607.
22. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, Chisari FV, Rehermann B, Del Prete G, Fiaccadori F, Ferrari C. 1996. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 98:1185-1194.
23. Pignatelli M, Waters J, Lever A, Iwarson S, Gerety R, Thomas HC. 1987. Cytotoxic T-cell responses to the nucleocapsid proteins of HBV in chronic hepatitis: evidence that antibody modulation may cause protracted infection. J Hepatol 4:15-21.
24. Rehermann B, Lau D, Hoofnagle JH, Chisari FV. 1996. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 97:1655-1665.
25. Summers J, Mason WS. 1982. Replication of the genome of a hepatitis-B-like virus by reverse transcription of an early RNA intermediate. Cell 29:403-415.
26. Sylvan SPE, Hellstrom UB, Flehmig B. 1987. Characterization of cell mediated immune responses to the hepatitis B core protein in man. Clin Exp Immunol 68:233-241.
27. Tiku ML, Beutner KR, Tiku K, Ogra PL. 1978. Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans. J Inf Dis 138: 587-596.
28. Tong MJ, Wallace AM, Peters RL, Reynolds TB. 1975. Lymphocyte stimulation in hepatitis B infections. N Engl J Med 293:318-322.
29. Vickery K, Freiman JS, Dixon RJ, Kearney R, Murray S, Cossart YE. 1989. Immunity in pekin ducks experimentally and naturally infected with duck hepatitis B virus. J Med Virol 28:231-26.
30. Vickery K, Pajkos A, Cossart YE. 1995. The in vitro response to mitogens by duck splenic mononuclear cells. Res Vet Sci 59:242-246.
31. Vickery K, Cossart YE. 1996. DHBV manipulation and prediction of the outcome of infection. J Hepatol 25:504-509.
32. Vickery K, Cossart YE, Gu X, Dixon RJ. 1997. Antigen-specific blastogenesis assays for duck hepatitis B virus using duck peripheral blood and splenic mononuclear cells. Vet Immunol Immunopathol 59:349-358.